UK regulator gives green light to combination for multiple myeloma
Drug Discovery World
SEPTEMBER 27, 2023
Seven years of trial data DLd is licensed and has been available for use in Europe since 2019. The positive Final Draft Guidance (FDG) follows a positive acceptance from the Scottish Medicines Consortium (SMC) for routine use in NHS Scotland this month.
Let's personalize your content